<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Predicting Cetuximab Response in Gastric Cancer using MCT

Gastric cancer (GC), specifically gastric adenocarcinoma, is one of the leading causes of cancer mortality worldwide, with a poor treatment outcome for the majority of patients. The modest response to chemotherapeutic treatments observed clinically has prompted research into novel therapies targeting the genetic and molecular alterations that drive gastric cancer carcinogenesis.